Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America
€ 173,90
Informação do Produto
| ISBN | 9780323813051 |
|---|---|
| Editora | Elsevier - Health Sciences Division |
| Formato | Capa dura |
| Número de páginas | 240 |
| Peso (kg) | 0,514 |
| Data de Publicação | 19/04/2021 |
| Preço (iva excl.) | € 164,06 |
| Imposto | € 9,84 |
| Preço (iva inc.) | € 173,90 |
| Disponibilidade | 4 unidades em armazém externo |
Descrição do Produto
This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include-but are not limited to-Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments.